Indian J Crit Care Med
February 2024
Objectives: Fecal microbiota transplantation (FMT) is an emerging option for recurrent or refractory -associated diarrhea (CDAD). We describe a single-center experience of FMT in hematopoietic stem cell transplant (HSCT) recipients with CDAD in India.
Methods: A prospective observational study of HSCT recipients with CDAD who received FMT in our center.
Indian J Crit Care Med
September 2023
Introduction: In the Indian setting, antimicrobial resistance in is a considerable problem, especially in intensive care units (ICUs). Due to the limited data, clinicians are left with very few choices except polymyxins for treating serious infections caused by . There is sparse data regarding the local mechanisms of resistance.
View Article and Find Full Text PDF: Prayag PS. Author Reply: Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India. Indian J Crit Care Med 2023;27(6):451.
View Article and Find Full Text PDFIntroduction: Isavuconazole is an emerging therapeutic option for invasive infections caused by molds, especially aspergillosis and mucormycosis. Isavuconazole has predictable pharmacokinetics and good bioavailability. These attributes have led to some doubts regarding the need for therapeutic drug monitoring (TDM).
View Article and Find Full Text PDF